CRP and head and neck squamous cell carcinoma: Several previous studies have shown that both increased systemic CRP levels [8,47,48,49,50,51,52] and IL6 levels [9,21,22,23,53,54,55,56,57] are associated with an adverse prognosis in HNSCC.